- Agency 100
- Partner Content
Key insights on topics from HCP and patient engagement to leveraging AI from MM+M’s most recent roundtable discussions with pharma and med-tech executives
MM+M’s latest #TrendTalks discussion with A-level marketers from biopharma companies and other healthcare companies on September 20 was timed to coincide with the start of the 2024 budget-planning season. This gave the senior-level participants a timely opportunity to compare notes on which channels they’re interested in for the coming year and audience strategy, including the latest in HCP and patient engagement preferences.
Moderated by MM+M’s editor-at-large Marc Iskowitz, the discussions shed light on timely topics including:
● Where and how machine learning (ML) and artificial intelligence (AI) can be leveraged throughout the commercial value chain
● How to make better use of the commercial data platform
● The ways marketers are personalizing non-personal promotion (NPP)
● Influencers as a communication conduit in oncology and other areas
● And much more
The senior-level marketers also discussed a number of issues the industry is grappling with on the path toward crossing the tech-awareness chasm; how non-endemic channels have reset the direct-to-patient (DTP) media equation in cancer; and the power of storytelling and ways of learning “fact wrapped in emotion.”
Download this eBook to glean the important insights and takeaways shared by the esteemed group at MM+M’s most recent #TrendTalks event.
Offered Free by: MM+M
See All Resources from: MM+M